Selected research
Industry Research
Glyburide Industry Research Report 2026
Market perspective
The global Glyburide market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Glyburide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Glyburide is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Glyburide is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Glyburide include Sunlight Pharmaceutical, Double Whale Pharmaceutical, Shapuaisi Pharma, Novartis, Jisheng Medicine, CR Sanjiu, Bohai Pharmaceutical, Sanofi Aventis and Physicians Total Care, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Glyburide market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Glyburide Market by Company
Sunlight Pharmaceutical
Double Whale Pharmaceutical
Shapuaisi Pharma
Novartis
Jisheng Medicine
CR Sanjiu
Bohai Pharmaceutical
Sanofi Aventis
Physicians Total Care
Hoechst Canada
Hikma Pharmaceuticals
Dominion Pharmacal
Cadila Pharmaceuticals
Avanstra
Apotex Corporation
Amneal Pharmaceuticals
Glyburide Segment by Type
1.25mg
2.5mg
5mg
Glyburide Segment by Application
Pediatric Use
Geriatric Use
Others
Glyburide Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glyburide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glyburide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glyburide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Glyburide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Glyburide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Glyburide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1.25mg
- 2.5mg
- 5mg
Applications
- Pediatric Use
- Geriatric Use
- Others
Companies covered
- Sunlight Pharmaceutical
- Double Whale Pharmaceutical
- Shapuaisi Pharma
- Novartis
- Jisheng Medicine
- CR Sanjiu
- Bohai Pharmaceutical
- Sanofi Aventis
- Physicians Total Care
- Hoechst Canada
- Hikma Pharmaceuticals
- Dominion Pharmacal
- Cadila Pharmaceuticals
- Avanstra
- Apotex Corporation
- Amneal Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Glyburide Market Size (2021-2032)
- 2.2.2 Global Glyburide Sales (2021-2032)
- 2.2.3 Global Glyburide Market Average Price (2021-2032)
- 2.3 Glyburide by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 1.25mg
- 2.3.3 2.5mg
- 2.3.4 5mg
- 2.4 Glyburide by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pediatric Use
- 2.4.3 Geriatric Use
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Glyburide Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Glyburide Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Glyburide Revenue of Manufacturers (2021-2026)
- 3.4 Global Glyburide Average Price by Manufacturers (2021-2026)
- 3.5 Global Glyburide Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Glyburide, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Glyburide, Product Type & Application
- 3.8 Global Manufacturers of Glyburide, Established Date
- 3.9 Global Glyburide Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sunlight Pharmaceutical
- 4.1.1 Sunlight Pharmaceutical Company Information
- 4.1.2 Sunlight Pharmaceutical Business Overview
- 4.1.3 Sunlight Pharmaceutical Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sunlight Pharmaceutical Glyburide Product Portfolio
- 4.1.5 Sunlight Pharmaceutical Recent Developments
- 4.2 Double Whale Pharmaceutical
- 4.2.1 Double Whale Pharmaceutical Company Information
- 4.2.2 Double Whale Pharmaceutical Business Overview
- 4.2.3 Double Whale Pharmaceutical Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Double Whale Pharmaceutical Glyburide Product Portfolio
- 4.2.5 Double Whale Pharmaceutical Recent Developments
- 4.3 Shapuaisi Pharma
- 4.3.1 Shapuaisi Pharma Company Information
- 4.3.2 Shapuaisi Pharma Business Overview
- 4.3.3 Shapuaisi Pharma Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shapuaisi Pharma Glyburide Product Portfolio
- 4.3.5 Shapuaisi Pharma Recent Developments
- 4.4 Novartis
- 4.4.1 Novartis Company Information
- 4.4.2 Novartis Business Overview
- 4.4.3 Novartis Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Novartis Glyburide Product Portfolio
- 4.4.5 Novartis Recent Developments
- 4.5 Jisheng Medicine
- 4.5.1 Jisheng Medicine Company Information
- 4.5.2 Jisheng Medicine Business Overview
- 4.5.3 Jisheng Medicine Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Jisheng Medicine Glyburide Product Portfolio
- 4.5.5 Jisheng Medicine Recent Developments
- 4.6 CR Sanjiu
- 4.6.1 CR Sanjiu Company Information
- 4.6.2 CR Sanjiu Business Overview
- 4.6.3 CR Sanjiu Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 CR Sanjiu Glyburide Product Portfolio
- 4.6.5 CR Sanjiu Recent Developments
- 4.7 Bohai Pharmaceutical
- 4.7.1 Bohai Pharmaceutical Company Information
- 4.7.2 Bohai Pharmaceutical Business Overview
- 4.7.3 Bohai Pharmaceutical Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bohai Pharmaceutical Glyburide Product Portfolio
- 4.7.5 Bohai Pharmaceutical Recent Developments
- 4.8 Sanofi Aventis
- 4.8.1 Sanofi Aventis Company Information
- 4.8.2 Sanofi Aventis Business Overview
- 4.8.3 Sanofi Aventis Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sanofi Aventis Glyburide Product Portfolio
- 4.8.5 Sanofi Aventis Recent Developments
- 4.9 Physicians Total Care
- 4.9.1 Physicians Total Care Company Information
- 4.9.2 Physicians Total Care Business Overview
- 4.9.3 Physicians Total Care Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Physicians Total Care Glyburide Product Portfolio
- 4.9.5 Physicians Total Care Recent Developments
- 4.10 Hoechst Canada
- 4.10.1 Hoechst Canada Company Information
- 4.10.2 Hoechst Canada Business Overview
- 4.10.3 Hoechst Canada Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Hoechst Canada Glyburide Product Portfolio
- 4.10.5 Hoechst Canada Recent Developments
- 4.11 Hikma Pharmaceuticals
- 4.11.1 Hikma Pharmaceuticals Company Information
- 4.11.2 Hikma Pharmaceuticals Business Overview
- 4.11.3 Hikma Pharmaceuticals Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Hikma Pharmaceuticals Glyburide Product Portfolio
- 4.11.5 Hikma Pharmaceuticals Recent Developments
- 4.12 Dominion Pharmacal
- 4.12.1 Dominion Pharmacal Company Information
- 4.12.2 Dominion Pharmacal Business Overview
- 4.12.3 Dominion Pharmacal Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Dominion Pharmacal Glyburide Product Portfolio
- 4.12.5 Dominion Pharmacal Recent Developments
- 4.13 Cadila Pharmaceuticals
- 4.13.1 Cadila Pharmaceuticals Company Information
- 4.13.2 Cadila Pharmaceuticals Business Overview
- 4.13.3 Cadila Pharmaceuticals Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Cadila Pharmaceuticals Glyburide Product Portfolio
- 4.13.5 Cadila Pharmaceuticals Recent Developments
- 4.14 Avanstra
- 4.14.1 Avanstra Company Information
- 4.14.2 Avanstra Business Overview
- 4.14.3 Avanstra Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Avanstra Glyburide Product Portfolio
- 4.14.5 Avanstra Recent Developments
- 4.15 Apotex Corporation
- 4.15.1 Apotex Corporation Company Information
- 4.15.2 Apotex Corporation Business Overview
- 4.15.3 Apotex Corporation Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Apotex Corporation Glyburide Product Portfolio
- 4.15.5 Apotex Corporation Recent Developments
- 4.16 Amneal Pharmaceuticals
- 4.16.1 Amneal Pharmaceuticals Company Information
- 4.16.2 Amneal Pharmaceuticals Business Overview
- 4.16.3 Amneal Pharmaceuticals Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Amneal Pharmaceuticals Glyburide Product Portfolio
- 4.16.5 Amneal Pharmaceuticals Recent Developments
5 Global Glyburide Market Scenario by Region
- 5.1 Global Glyburide Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Glyburide Sales by Region: 2021-2032
- 5.2.1 Global Glyburide Sales by Region: 2021-2026
- 5.2.2 Global Glyburide Sales by Region: 2027-2032
- 5.3 Global Glyburide Revenue by Region: 2021-2032
- 5.3.1 Global Glyburide Revenue by Region: 2021-2026
- 5.3.2 Global Glyburide Revenue by Region: 2027-2032
- 5.4 North America Glyburide Market Facts & Figures by Country
- 5.4.1 North America Glyburide Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Glyburide Sales by Country (2021-2032)
- 5.4.3 North America Glyburide Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Glyburide Market Facts & Figures by Country
- 5.5.1 Europe Glyburide Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Glyburide Sales by Country (2021-2032)
- 5.5.3 Europe Glyburide Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Glyburide Market Facts & Figures by Country
- 5.6.1 Asia Pacific Glyburide Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Glyburide Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Glyburide Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Glyburide Market Facts & Figures by Country
- 5.7.1 South America Glyburide Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Glyburide Sales by Country (2021-2032)
- 5.7.3 South America Glyburide Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Glyburide Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Glyburide Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Glyburide Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Glyburide Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Glyburide Sales by Type (2021-2032)
- 6.1.1 Global Glyburide Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Glyburide Sales Market Share by Type (2021-2032)
- 6.2 Global Glyburide Revenue by Type (2021-2032)
- 6.2.1 Global Glyburide Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Glyburide Revenue Market Share by Type (2021-2032)
- 6.3 Global Glyburide Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Glyburide Sales by Application (2021-2032)
- 7.1.1 Global Glyburide Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Glyburide Sales Market Share by Application (2021-2032)
- 7.2 Global Glyburide Revenue by Application (2021-2032)
- 7.2.1 Global Glyburide Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Glyburide Revenue Market Share by Application (2021-2032)
- 7.3 Global Glyburide Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Glyburide Value Chain Analysis
- 8.1.1 Glyburide Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Glyburide Production Mode & Process
- 8.2 Glyburide Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Glyburide Distributors
- 8.2.3 Glyburide Customers
9 Global Glyburide Analyzing Market Dynamics
- 9.1 Glyburide Industry Trends
- 9.2 Glyburide Industry Drivers
- 9.3 Glyburide Industry Opportunities and Challenges
- 9.4 Glyburide Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst